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Dendritic cell maturation by innate lymphocytes:
coordinated stimulation of innate and adaptive immunity
Christian Münz, Ralph M. Steinman, and Shin-ichiro Fujii

DC maturation, first proposed as a critical step in immunogenicity 20 years
ago, is now accepted as a crucial component of the induction of most adaptive
immune responses. The term maturation
refers to an intricate differentiation
process whereby DCs respond rapidly
to an environmental stimulus and become capable of eliciting adaptive immunity. The type of stimulus determines the
program of DC differentiation and the
subsequent host immune response. DCs
can directly sense pathogen components via TLRs, and respond to this
recognition by up-regulating surface
costimulatory molecules, secreting cytokines and chemokines, enhancing
antigen presentation, and migrating to
secondary lymphoid tissues (1). Some
features of DC maturation, such as the
up-regulation of CD86, can be induced by proinflammatory cytokines,
but cytokines alone seem insufficient
for the induction of adaptive immunity
in vivo (2, 3). Additional changes can
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be imparted to the DCs by CD40 ligation, which contributes to the generation of both CD4 and CD8 T cell immunity (2).
Innate immune cells also sense infections and cellular transformation via
receptors other than TLRs. We will
first summarize recently identified molecular mechanisms used by NK cells,
NKT cells, and  T cells to detect
infected and transformed cells, then
release cytokines such as interferon
(IFN)- and exert cytolytic activity.
These recognition mechanisms are now
being placed into the context of DC
biology. We will consider how innate
lymphocytes induce DC maturation,
which in turn expands the numbers
and function of both innate and adaptive lymphocytes. We propose that the
interaction of DCs with innate lymphocytes represents a major control
mechanism for immunity that is independent of TLR ligands.
Detection of viruses and tumors
by NK cells

NK cells, originally defined by their
ability to lyse tumor cells without prior
activation, recognize their targets via
activating and inhibitory receptors (4).
The balance of signals transmitted by
these receptors determines whether
NK cells are inhibited or activated.
Activating NK cell receptors include
Ly49H, the natural cytotoxicity receptors (NCRs), and NKG2D (4). Ly49H
in mice and the NCRs NKp46 and
NKp44 in humans directly recognize

JEM © The Rockefeller University Press $8.00
Vol. 202, No. 2, July 18, 2005 203–207 www.jem.org/cgi/doi/10.1084/jem.20050810

viral proteins on the surface of infected
cells. Ly49H detects the m157 protein
of murine cytomegalovirus (MCMV)
and is essential for the resistance to
MCMV infection in mice (4). The sialylated forms of NKp44 and NKp46
recognize hemaglutinins of para- and
orthomyxoviridae, such as influenza, on
the surface of infected cells (5). The
nature of NCR ligands on transformed
cells remains unclear, although heparan
sulfate proteoglycans have been implicated in the NKp30- and NKp46mediated NK cell recognition of adenocarcinoma cell lines (6). Furthermore,
it has been established that NCRs are
the main activating receptors for NK
cell recognition of melanoma and B
cell lymphomas (7).
Much more is known about the
tumor-associated ligands of NKG2D
(4). Both in humans and mice, NKG2D
recognizes self-molecules expressed on
the cell surface upon transformation or
infection. In humans, these include the
MHC class I chain-related proteins A
and B (MICA and MICB) and UL16
binding proteins (ULBP1-4) and, in
mice, the retinoic acid early inducible 1
protein family (Rae1-), H60, and murine ULBP-like transcript 1 (MULT1)
(4). These NKG2D ligands are found
on some melanomas, carcinomas, and
T cell lymphomas (7). In sum, activating
NK cell receptors can recognize virusinfected or transformed cells by binding
to virus surface proteins or to up-regulated self-proteins that are ligands for
NKG2D.
NK cell activation is further enhanced by the absence of NK cell inhibition. The inhibitory NK receptors of
the CD94/NKG2, Ly49, and killer cell
immunoglobulin-like receptor (KIR)
families recognize classical and nonclassical MHC class I molecules (4). Multiple
viral proteins, especially of the herpes203
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Pathogen recognition by Toll-like receptors (TLRs) on dendritic cells (DCs) leads
to DC maturation and the initiation of adaptive immunity. Recent studies have
shown that innate lymphocytes—natural killer (NK), natural killer T (NKT), and
 T cells—also trigger DC maturation. This interaction in turn expands and
activates innate lymphocytes and initiates adaptive T cell immunity. Here, we
comment on the evidence that these pathways are TLR independent and have
the potential to respond to infection, malignancy, and immunotherapy.
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can be induced to present isoglobotrihexosylceramide upon TLR ligation by
gram-positive bacteria like Salmonella typhimurium (10). Therefore, both self and
microbial glycolipids presented on CD1d
can elicit NKT cell activation.

Detection of glycolipids on CD1d
by NKT cells

 T cells, which express  TCRs instead of the  TCRs found on classical
T cells, recognize microbial and tumor
antigens, typically small pyrophosphomonoesters and alkylamines (15). Similar to NK and NKT cells,  T cells
can also recognize microbial products
and self-molecules on infected or tumor
cells, including small organic molecules,
chaperone proteins, or nonclassical MHC
class I molecules. Pyrophosphomonoesters,
including isopentenyl pyrophosphate,
are natural antigens from Mycobacteria
such as M. tuberculosis (15) or accumulate
as mevalonate metabolites in tumor cells
such as breast carcinoma, facilitating recognition of tumors by invariant  T
cells (16). The same invariant  T cell
population detects bacterial alkylamines
(15) and aminobiphosphonates, which
are synthetic compounds used in cancer
therapy (17). Other  T cell populations recognize mycobacterial and tumor-derived HSP60 molecules (15). In
addition, some murine  T cells seem
to directly recognize viral surface proteins such as herpes simplex virus glycoprotein I (15). Finally, nonclassical
MHC class I molecules stimulate distinct
 T cells. MICA and MICB are recognized by human intestinal  T cells
(18), and the MHC class Ib T10/T22
antigens bind to murine  T cell receptors (19). As is the case for NK cell
recognition, these nonclassical MHC
class I molecules are thought to be upregulated upon cell transformation and
infection. Moreover, in humans a subpopulation of peripheral blood  T
cells is also restricted by the nonclassical MHC class I molecule CD1c,
which presents microbial glycolipids
(15). In sum,  T cells recognize infected and transformed cells via a diverse set of ligands that range from
small organic compounds to pathogen-

Invariant NKT cells, which express both
NK cell markers and T cell receptors
(TCRs) that use a single V chain, recognize foreign and self-glycolipids presented by the nonclassical MHC class I
molecule CD1d (8). Natural CD1d
ligands are currently being identified.
One example is lipophosphoglycan from
Leishmania donovani, a constituent of the
parasitic surface glycocalyx, which stimulates IFN- secretion by a subset of hepatic mouse NKT cells (9). Glycosylceramides from the gram-negative bacteria
Ehrlichia muris and certain Sphingomonas
species, and phosphatidylinositol mannoside from mycobacterial membranes, are
also recognized by human and mouse
NKT cells (10–12). There is also evidence that glycolipids, possibly glycosylphosphatidylinositol from Plasmodium
and Trypanosoma parasites, are detected
by NKT cells (8). NKT cell stimulation
by other pathogens such as Salmonella
typhimurium, Staphylococcus aureus, and
Pseudomonas aeruginosa has also been reported (8), but specific CD1d ligands
from these organisms have not been
identified. These findings suggest that
NKT cells are primarily involved in the
detection of bacterial and parasitic pathogens, whereas NK cell activity is focused
on recognition of viral infections.
Similar to NK cells, NKT cells are
able to detect altered self-ligands. The
ganglioside GD3, which is overexpressed on human melanoma cells, can
be cross-presented on CD1d to mouse
NKT cells (13). Most recently, the lysosomal glycosphingolipid isoglobotrihexosylceramide was shown to be a
potent CD1d-restricted self-ligand that
stimulates mouse NKT cells (14). In fact,
a lack of isoglobotrihexosylceramide results in severe NKT cell deficiency. DCs
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Detection of microbial antigens
and tumors by  T cells

derived antigens and stress-induced
self-molecules.
Dendritic cell maturation by NK, NKT,
and  T cells

DC maturation has been documented in
vitro and in vivo after NK cell recognition of MHC class Ilow tumor cells (20),
NKT cell stimulation by the synthetic
invertebrate glycolipid -galactosylceramide (-GalCer) presented on DC
CD1d molecules (21, 22), and activation
of phosphoantigen-specific and CD1crestricted  T cell subsets (23, 24). After
activation, all three innate lymphocyte
populations were able to induce DC
maturation as evidenced by increased expression of CD86, IL-12 production,
and priming of T cell responses (2, 20,
22–25). TNF has been identified as a
crucial inducer of DC maturation in
these studies (2, 23–26). In addition,
CD40–CD40L interactions induced by
NKT cells allowed for priming of adaptive immune responses by DCs (2).
Thus, NK, NKT, and  T cells mature
DCs by a combination of cytokine- and
cell contact–dependent signals.
In turn, matured DCs also stimulate
NK, NKT, and  T cells for sustained
innate immune responses (21, 24, 26–
28). IL-12, IL-15, IL-2, and IFN/,
which are all produced by maturing
DCs, contribute to the activation of
different NK cell functions (29–31).
This interaction likely takes place at
sites of infection and in secondary lymphoid organs (27).
An important component of DC
maturation is the ability of the DC to
mediate lymphocyte differentiation.
The interaction of NK cells with DCs
in vivo assists in the T helper type 1
(Th1) cell polarization of primary immune responses, most likely via secretion of the Th1 cell–promoting cytokine IFN- by the NK cells (32). The
interaction of NKT cells with antigencapturing DCs likewise allows for the
induction of antigen-specific, IFN-–
producing CD4 and CD8 T cells
(2). Thus, when DCs are matured by
NK, NKT, and  T cells, the DCs
both augment innate responses and
prime adaptive immunity.

INNATE LYMPHOCYTES MATURE DCS | Munz et al.
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viridae family, down-regulate the expression of MHC class I molecules or
antigen processing (4). As a result of the
loss of MHC class I molecules, or “missing self,” inhibitory NK cell receptors
are not engaged, which results in enhanced NK cell activation and destruction of transformed and infected cells.
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Comparing DC maturation induced by
TLRs or innate lymphocytes

DC activation by innate lymphocytes
in immunotherapy

It should prove fruitful to harness innate lymphocyte-mediated DC maturation for immunotherapy, because the
innate lymphocytes themselves have

JEM VOL. 202, July 18, 2005

Figure 1. Innate lymphocytes mature DCs. Innate lymphocytes, including  T, NKT, and NK cells
recognize pathogen-derived and self-antigens on infected cells, tumors, and stressed self-tissues
(left). Their activation leads to DC maturation, presumably under conditions where the DCs are also
presenting ligands recognized by innate lymphocytes. The DCs thus expand the innate response
(bottom right) and also elicit adaptive immunity to processed antigens (top right), including those
derived from cells lysed by innate lymphocytes. Cytokines and cell contact–dependent molecules
mediate DC activation by different types of innate lymphocytes, whereas DCs produce cytokines that
expand and differentiate additional innate and adaptive lymphocytes.

direct antitumor functions and they can
mobilize an adaptive immune response
via DCs. In other words, they act as
adjuvants. A recent study showed that
NKT cell activation induced by -GalCer–pulsed immature DCs also provoked NK and T cell expansion in
patients with metastatic malignancies
(34). This study suggested that DCs activated by one population of innate
lymphocytes, such as NKT cells, can
activate another group of innate lymphocytes, such as NK cells, to induce
antitumor effects. In another recent
study (28), mature -GalCer–pulsed
DCs induced a 100-fold expansion of
NKT cells, which was sustained for up
to 6 months after vaccination. This
treatment also boosted memory T cell
responses against a persistent human
cytomegalovirus antigen, but not
against influenza antigens, except in
one patient, likely due to the reintroduction of influenza antigens from a recent vaccination. These data suggest
that NKT cell–mediated immune activation can lead to enhanced T cell responses against antigens present in the
patient, possibly as a result of NKT
cell–mediated maturation of DCs that

can present antigenic peptides. Another
study showed that  T cells could be
stimulated with the aminobiphosphonate pamidronate plus low-dose IL-2
in relapsed non-Hodgkin lymphoma
and multiple myeloma patients (17). In
patients whose  T cells expanded in
response to pamidronate and IL-2 in
vitro, the treatment led to increased
numbers of  T cells in the peripheral
blood in 55% of patients and to clinical
improvement in 33% of the patients.
However, the induction of adaptive T
cell immunity was not analyzed in this
patient cohort. Finally, allogeneic hematopoetic stem cell transplantation
mediates a graft-versus-leukemia effect,
which has been ascribed to detection of
mismatched HLA molecules by NK
cells (35). This would suggest a major
role for suitably activated NK cells in
direct resistance to human leukemia.
The effect on adaptive antileukemia
immune responses has yet to be evaluated. With these initial results on innate
lymphocyte activation in immunotherapy, NK, NKT, and  T cell stimuli
should be considered in addition to
TLR stimuli as adjuvants for DC-based
vaccines as a way to enhance both in-
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DC maturation is a sensor that links innate immune responses to adaptive
ones. During TLR-mediated DC maturation, distinct TLR ligands likely evoke
distinct responses in DCs (1). This signaling complexity is further increased by
the expression of distinct TLRs on different DC subsets, as well as by the differences in adaptor molecules used by
different TLRs (1). One difference between TLR-induced versus innate lymphocyte-induced DC maturation is the
nature of the ligands. TLRs bind microbial constituents (protein, DNA, and
RNA) or autoantigens that erroneously
mimic these pathogen components (33).
NK, NKT, and  T cells can also be
activated by self-molecules, but these
serve as desirable molecular beacons to
signal infection or transformation of
cells that display these molecules (4, 10,
15). This altered self-recognition by innate lymphocytes allows DC maturation
in response to tumors or other stresses,
which may not express TLR ligands. In
addition, TLR ligands stimulate many
cell types, including epithelial cells, and
lead to systemic responses, whereas DC
maturation in response to innate lymphocytes is potentially a much more local and very early event that is restricted
to the site of innate lymphocyte activation. In sum, NK, NKT, and  T cells
have considerable potential to induce
protective DC maturation after both local expression of stress-induced molecules and systemic spreading of pathogen-derived constituents.
Innate lymphocytes can also provide antigenic material for DCs. Fragments of infected or tumor cells, generated during the destruction of target
cells by innate lymphocytes, are taken
up by DCs and displayed on MHC
molecules, thus eliciting an adaptive T
cell response in vivo (20) (Fig. 1).
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nate and adaptive immune responses
against infectious diseases and tumors.
Conclusions
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Molecular mechanisms are being identified to explain how innate NK, NKT,
and  T cells detect infected and transformed cells, and directly provide resistance at the level of cytolysis and cytokine production. Another new area
relates to the consequences of innate
lymphocyte interactions with DCs. First,
the innate cells induce DC maturation
through cell contact mechanisms that remain to be unraveled. Second, the DCs
expand the number and enhance the
function of the innate lymphocytes. Finally, maturing DCs process antigens,
particularly from cells lysed by innate
lymphocytes, and elicit adaptive Th1type immunity. This newly recognized
cross talk between DCs and innate lymphocytes, which seems to occur largely
in the secondary lymphoid organs, is
starting to be exploited for therapeutic
purposes, because innate lymphocytes
serve as attractive adjuncts for tumor resistance and also as adjuvants for initiating antigen-specific, cell-mediated immunity. Major goals for the future are to
identify mechanisms by which DCs expand and activate innate lymphocytes, to
understand the role of lymphoid organs
as sites where DCs and innate cells interact to initiate adaptive immunity, and to
harness these pathways in therapy and
perhaps vaccination.
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